Minimal-activity PET/CT for efficacy control after SIRT (MAPECSI) - clinical implementation of a resource-saving, liver-focused protocol.

CONCLUSION:  Minimal-Activity FDG-PET/CT of the liver is a feasible tool for efficacy assessment after SIRT with low financial and radiation burden. It provides additional information to morphologic imaging modalities, which can be helpful in response appraisal and treatment planning.
PMID: 31412374 [PubMed - as supplied by publisher]

Source: Nuklearmedizin - August 13, 2019 Category: Radiology Authors: Gühne F, Drescher R, Seifert P, Freesmeyer M Tags: Nuklearmedizin Source Type: research